Reviews

Issue 3.2

The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study

Mark Danta , N Ghinea

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations

Samuel A Garner , Stuart Rennie , Jintanat Ananworanich , Karine Dube , David M Margolis , Jeremy Sugarman , Randall Tressler , Adam Gilbertson , Liza Dawson

Original research

A CD3|CD28 microbead-based HIV-1 viral outgrowth

Yuri V Kuzmichev , Rebecca T Veenhuis , Christopher W Pohlmeyer , Caroline C Garliss , Victoria EK Walker-Sperling , Joel N Blankson

Viewpoints

The ‘post-condom era’ or the urgent need to provide effective contraception for women living with HIV

Karoline Aebi-Popp

Conference report

Highlights from the HIV Research for Prevention Conference (R4P), 17–21 October 2016, Chicago, IL, USA

Sandhya Vasan , Tanyaporn Wansom , Alexandra Schuetz , Shelly Krebs , Rasmi Thomas , Gustavo Kijak , Christina Polyak

Highlights of the International Congress on Drug Therapy in HIV Infection, 23–26 October 2016, Glasgow, UK

Julio Montaner , Pablo Rojo , Tarandeep Anand , Jurgen Rockstroh

Highlights from the 24th Conference on Retroviruses and Opportunistic Infections 13–16 February 2017, Seattle, Washington, USA

Trevor A Crowell , Hermione Lyall , Eva Malatinkova , Sanjay Bhagani , Denise Hsu , Donn J Colby , Christina Polyak , Christina Psomas , Andrew Hill , Esther N Gathogo , Wim Trypsteen , Linos Vanderkerckhove , Sabine Kinloch


Back to top